{
  "column-order": [
    "Ampicillin",
    "Amoxicillin/clavulan",
    "Ampicillin/Sulbactam",
    "Piperacillin/tazobactam",
    "Cefazolin",
    "Cefepime",
    "Ceftazidime",
    "Ceftriaxone",
    "Ertapenem",
    "Meropenem",
    "Ciprofloxacin",
    "Levofloxacin",
    "Gentamicin",
    "Tobramycin",
    "Amikacin",
    "Tetracycline",
    "Minocycline",
    "Trimethoprim/sulfamethoxazole",
    "Nitrofurantoin",
    "Clindamycin",
    "Erythromycin",
    "Azithromycin",
    "Oxacillin",
    "Penicillin",
    "Vancomycin",
    "Rifampin",
    "Daptomycin",
    "Linezolid",
    "Gentamicin-Synergy"
  ],
  "row-order": [
    "ESCHERICHIA COLI",
    "ESCHERICHIA COLI (URINE ISOLATES)",
    "KLEBSIELLA PNEUMONIAE",
    "SERRATIA MARCESCENS",
    "ENTEROBACTER CLOACAE COMPLEX",
    "PROTEUS MIRABILIS",
    "KLEBSIELLA OXYTOCA",
    "PSEUDOMONAS AERUGINOSA",
    "ENTEROCOCCUS SP., VSE",
    "ENTEROCOCCUS SP., VRE",
    "STAPH. AUREUS, MSSA",
    "STAPH. AUREUS, MRSA",
    "STAPHYLOCOCCUS EPIDE-",
    "STAPH. SPECIES,  COAG.NEG",
    "STENOTROPH MALTOPHILIA COMM WIDE",
    "ACINETOBACT BAUMANII COMM WIDE",
    "STREP PNEUMONIAE COMM WIDE",
    "HAEM INFLUENZAE COMM WIDE"
  ],
  "footnotes": [
    "For uncomplicated UITâ€™s, Cefazolin MIC results less than or equal to 16 mcg/ml predict susceptibility of the following oral cephalosporins: cefactor, cefdinnir, cefpodoxime, cefprozil cefuroxime and cephalexin.",
    "Oxacillin susceptible Staph are also susceptible to other penicillinase resistant penicillins, betalactam/betalactamase inhibitor combinations, cephems,and carbapenems FDA approved to treat Staph infections.",
    "Gentamicin and Rifampin may be used in combination with other drugs against Staph isolates.",
    "The percentages that are greater than or equal to 80% susceptibility are potentially useful for empiric therapy."
  ],
  "resistance-rates": []
}
